1
|
Zhang G, Wang R, Qiao X, Li J. Primary Epithelial-Myoepithelial Carcinoma of the Lung Presenting as Multiple Synchronous Lesions. Ann Thorac Surg 2023; 115:e17-e19. [PMID: 35278413 DOI: 10.1016/j.athoracsur.2022.02.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 02/02/2022] [Accepted: 02/26/2022] [Indexed: 12/31/2022]
Abstract
Primary epithelial-myoepithelial carcinoma of the lung is an extremely rare histologic form that originates in the bronchial glands. Pulmonary epithelial-myoepithelial carcinoma in the peripheral lung is extremely rare, and multiple primary pulmonary epithelial-myoepithelial carcinoma has not been reported to date. Here, we report a case of pulmonary epithelial-myoepithelial carcinoma presenting as multiple synchronous lesions. The patient underwent two treatments by video-assisted thoracic surgery within 3 years. At the 4-month follow-up, the patient had no evidence of recurrence. In conclusion, our case report may contribute to the understanding of pulmonary epithelial-myoepithelial carcinoma.
Collapse
Affiliation(s)
- Guoliang Zhang
- Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
| | - Rui Wang
- Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
| | - Xueying Qiao
- Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
| | - Jing Li
- Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
| |
Collapse
|
2
|
Pulmonary Epithelial-Myoepithelial Carcinoma. JOURNAL OF ONCOLOGY 2022; 2022:4559550. [PMID: 36268279 PMCID: PMC9578788 DOI: 10.1155/2022/4559550] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Accepted: 09/21/2022] [Indexed: 11/17/2022]
Abstract
Pulmonary epithelial-myoepithelial carcinoma (P-EMC) is an exceptionally rare subtype of salivary gland lung tumor originating from tracheobronchial glands. P-EMC is a biphasic tumor consisting of an inner layer of epithelial cells and an outer layer of spindle-shaped, clear-cell-like myoepithelial cells. Bronchial obstruction symptom is the main clinical characteristic for P-EMC. Because its clinical and imaging characteristics are highly similar to other types of non-small-cell lung cancer (NSCLC), it is easy to cause missed diagnosis and misdiagnosis. The diagnosis is mainly based on the pathology and immunohistochemistry with an inner layer of epithelial cells immunoreactive for cytokeratin and an outside layer of myoepithelial cells immunoreactive for S100 protein (S-100) and smooth muscle actin (SMA). Therefore, positive for cytokeratin, S-100 and SMA can assist in the diagnosis. Although in general, P-EMC is a low-grade malignant neoplasm, it may occasionally recur and metastasize. The optimal method for P-EMC treatment has not been established, and surgical resection is still the main clinical method. Radiotherapy and chemotherapy have been shown not sensitive for P-EMC treatment, whereas targeted therapy and immunotherapy have not evaluated in clinical practice. This review focuses on the pathological characteristics, molecular characteristics, diagnosis, treatment, and prognosis of P-EMC.
Collapse
|
3
|
Zhang W, Wang XX, Wang XL, Zhang Y, Li XF, Li Y, Cai YY, Ren HQ, Zhang YX, Hao FR. Epithelial-myoepithelial carcinoma of the nasopharynx: A case report and review of the literature. Front Oncol 2022; 12:923579. [PMID: 35992786 PMCID: PMC9389165 DOI: 10.3389/fonc.2022.923579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Accepted: 06/30/2022] [Indexed: 11/13/2022] Open
Abstract
Background Epithelial-myoepithelial carcinoma (EMCa) is a rare low-grade malignant tumor that most commonly occurs in the salivary glands, with approximately 320 cases having been reported worldwide. Here, we report the third case of EMCa occurring in the nasopharynx. Rare cases in the breast, pituitary gland, lacrimal gland, nose, paranasal sinus, nasal cavity, trachea and bronchus, lung, and even the pleura mediastinalis have also been reported. Histopathology and immunohistochemistry are useful for confirming the diagnosis of EMCa, which is characterized by biphasic tubular structures composed of inner ductal and outer clear myoepithelial cells and stains for different markers in each layer. However, because of the rarity of EMCa, the clinicopathological characteristics and treatment of these patients remain unclear. Case presentation We report a rare case of EMCa of the nasopharynx. A 51-year-old man presented with a 5-month history of pain while swallowing and aggravation accompanied by right ear tinnitus lasting for 1 month. Nasopharyngoscopy and magnetic resonance imaging (MRI) of the nasopharynx and neck revealed a 5.6 cm × 3.4 cm × 3.1 cm mass in the nasopharyngeal space, invasion of the right cavernous sinus, and lymph node enlargement in the right retropharyngeal space. On 17 April 2019, based on the histopathological and immunohistochemical features, a final diagnosis of EMCa of the right nasopharynx was made. The patient underwent concurrent chemoradiotherapy (CCRT), and his symptoms were relieved after treatment. On 10 January 2022, nasopharynx MRI and biopsy revealed local recurrence, but chest and abdominal computed tomography (CT) showed no obvious signs of metastasis. The local recurrence-free survival (LRFS) period was 33 months. Conclusion To the best of our knowledge, this is the third reported case of EMCa in the nasopharynx and the only case of EMCa in the nasopharynx treated with CCRT, and a partial response was achieved. Therefore, to improve the quality of life and prognosis of patients with unresectable tumors, we believe that CCRT is a suitable option. Further clinical observations are required to elucidate the pathophysiology and prognosis of EMCa.
Collapse
Affiliation(s)
- Wei Zhang
- Clinical School, Weifang Medical University, Weifang, China
| | - Xiao-xiao Wang
- Department of Radiation Oncology, Weifang People’s Hospital, Weifang, China
| | - Xiao-li Wang
- Department of Radiation Oncology, Weifang People’s Hospital, Weifang, China
| | - Yan Zhang
- Clinical School, Weifang Medical University, Weifang, China
| | - Xiu-feng Li
- Department of Pathology, Weifang People’s Hospital, Weifang, China
| | - Yang Li
- Department of Radiation Oncology, Weifang People’s Hospital, Weifang, China
| | - Yuan-yuan Cai
- Department of Radiation Oncology, Weifang People’s Hospital, Weifang, China
| | - Hui-qi Ren
- Department of Radiation Oncology, Weifang People’s Hospital, Weifang, China
| | - Yun-xiang Zhang
- Department of Pathology, Weifang People’s Hospital, Weifang, China
| | - Fu-rong Hao
- Department of Radiation Oncology, Weifang People’s Hospital, Weifang, China
- Weifang Key Laboratory of Radiophysics and Oncological Radiobiology, Weifang, China
| |
Collapse
|
4
|
Huang HC, Zhao L, Cao XH, Meng G, Wang YJ, Wu M. Primary salivary gland tumors of the lung: Two cases date report and literature review. Respir Med Case Rep 2020; 32:101333. [PMID: 33457200 PMCID: PMC7797914 DOI: 10.1016/j.rmcr.2020.101333] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2020] [Revised: 12/20/2020] [Accepted: 12/26/2020] [Indexed: 02/06/2023] Open
Abstract
Background Primary salivary gland-type tumors of the lung (PSGTTL) is a rare intrathoracic malignant tumor that accounts for all lungs <1% of tumors. Purpose To introduce two case reports of primary lung salivary gland tumors, and highlight their diagnosis and treatment challenges. Case report The first case was a 30-year-old female, who complained of repeated coughing and dyspnea for 1 year and worsening for 2 days. Chest CT and bronchoscopy showed new organisms in the lower part of the trachea, that the bronchus obstruction accounted for 70%. The biopsy histology revealed a adenoid cystic carcinoma. She underwent extensive surgical resection and multiple radiotherapy, and She is recovering well from follow-up. The second case was a 70-year-old man, who complained of intermittent sputum blood for 2 years, worsening hemoptysis and chest tightness for 3 months. The new organisms was found in the upper trachea from Chest CT and bronchoscopy, and histological biopsy was used to diagnose epithelial myoepithelial carcinoma. He underwent twice bronchoscopy thermal ablation treatments. The follow-up is currently in good condition. Conclusion Primary lung salivary gland tumors are considered to be rare malignant tumors in the lungs. Early detection is advocated as late presentation with advanced tumor presents diagnostic and therapeutic challenges.
Collapse
Affiliation(s)
- Hong-Chun Huang
- Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Lei Zhao
- Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Xiao-Hui Cao
- Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Gang Meng
- Clinic Pathology Center, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Yue-Jun Wang
- Clinic Pathology Center, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Min Wu
- Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| |
Collapse
|
5
|
Chen L, Li Q, Fu G, Ge M. [A Rare Case of Pulmonary Epithelial-myoepithelial Carcinoma: Case Report and Literature Review]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2020; 23:127-132. [PMID: 32093457 PMCID: PMC7049792 DOI: 10.3779/j.issn.1009-3419.2020.02.08] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
背景与目的 肺上皮-肌上皮癌(pulmonary epithelial-myoepithelial carcinoma, P-EMC)是一种十分罕见的涎腺型肺肿瘤,尚无标准治疗方案,本文拟分析肺上皮-肌上皮癌的临床特点,探讨肺上皮-肌上皮癌的诊疗方案。 方法 分析1例肺上皮-肌上皮癌患者的临床资料并回顾其他相关临床文献。 结果 上皮细胞免疫组化表达细胞角蛋白,肌上皮细胞免疫组化表达SMA及S-100,二代基因测序以HRAS基因突变为主,PD-L1蛋白为阴性。 结论 肺上皮-肌上皮癌大多预后良好,诊断以镜检及免疫组化为主,治疗以手术切除为主,放化疗效果尚不明确。
Collapse
Affiliation(s)
- Liang Chen
- Department of Thoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| | - Qingshu Li
- Department of Pathology, Chongqing Medical University, Chongqing 400016, China
| | - Guang Fu
- Department of Thoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| | - Mingjian Ge
- Department of Thoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| |
Collapse
|
6
|
Patterson DT, Halverson Q, Williams S, Bishop JA, Ochoa CD, Styrvoky K. Bronchoscopic management of a primary endobronchial salivary epithelial-myoepithelial carcinoma: A case report. Respir Med Case Rep 2020; 30:101083. [PMID: 32435581 PMCID: PMC7232110 DOI: 10.1016/j.rmcr.2020.101083] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Accepted: 05/05/2020] [Indexed: 12/29/2022] Open
Abstract
Here, we discussed a 55 y/o African man who recently immigrated from Nigeria to the United States and who presented to Parkland Memorial Hospital with a productive, intermittent cough of one year duration. The cough was associated with shortness of breath and chest pain. Cough was not associated with voice hoarseness, hemoptysis, melanoptysis, and wheezing. He had a computed tomography (CT) scan of the chest that showed a 1.9 cm mass in the right main stem bronchus with ipsilateral right lower lobe consolidation and bronchiectasis. The patient was seen by pulmonology who recommended bronchoscopy for diagnosis and possible intervention. Bronchoscopy showed a 90% obstructing mass in the proximal right mainstem bronchus and bronchus intermedius. The mass was large and endobronchial, circumferential, exophytic, and polypoid. The decision was made to undergo bronchoscopic tumor ablation using electrocautery snare, argon plasma coagulation (APC), suction, and forceps. The tumor was successful ablated. Microscopic examination revealed eosinophilic ducts tightly coupled with a surrounding layer of clear cell myoepithelial cells and the diagnosis of epithelial-myoepithelial carcinoma (EMC) of the lung was made. The patient was discharged from the hospital with scheduled outpatient visits for monitoring of the carcinoma by pulmonology and thoracic surgery. Unfortunately, he was lost to follow up. Primary salivary epithelial-myoepithelial carcinoma are extremely rare malignancies found in the airways. This type of tumor can be seen in patients who present with chronic cough without other symptomatology. Although management is primarily surgical, here we report the successful bronchoscopic removal of this malignancy. There were no complications following the bronchoscopic removal of the tumor.
Collapse
Affiliation(s)
- Dalton T. Patterson
- Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, 75239, USA
| | - Quinn Halverson
- Division of Pulmonary and Critical Care, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, 75239, USA
| | - Sarah Williams
- Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, 75239, USA
| | - Justin A. Bishop
- Department of Pathology, UT Southwestern Medical Center, Dallas, TX, 752393, USA
| | - Cristhiaan D. Ochoa
- Division of Pulmonary and Critical Care, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, 75239, USA
- Corresponding author. Division of Pulmonary and Critical Care, UT Southwestern Medical Center, Dallas, TX, 75239, USA.
| | - Kim Styrvoky
- Division of Pulmonary and Critical Care, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, 75239, USA
| |
Collapse
|